ZA200806929B - Nebulizer formulation - Google Patents
Nebulizer formulationInfo
- Publication number
- ZA200806929B ZA200806929B ZA200806929A ZA200806929A ZA200806929B ZA 200806929 B ZA200806929 B ZA 200806929B ZA 200806929 A ZA200806929 A ZA 200806929A ZA 200806929 A ZA200806929 A ZA 200806929A ZA 200806929 B ZA200806929 B ZA 200806929B
- Authority
- ZA
- South Africa
- Prior art keywords
- nebulizer formulation
- nebulizer
- formulation
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000006199 nebulizer Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0604141.2A GB0604141D0 (en) | 2006-03-01 | 2006-03-01 | Nebulizer formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200806929B true ZA200806929B (en) | 2009-11-25 |
Family
ID=36218946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200806929A ZA200806929B (en) | 2006-03-01 | 2007-03-01 | Nebulizer formulation |
Country Status (14)
Country | Link |
---|---|
US (1) | US20070207091A1 (xx) |
EP (1) | EP1988876A2 (xx) |
JP (1) | JP2009528337A (xx) |
KR (1) | KR20080098631A (xx) |
CN (1) | CN101394835A (xx) |
AU (1) | AU2007220288B2 (xx) |
BR (1) | BRPI0708170A2 (xx) |
CA (1) | CA2643761A1 (xx) |
GB (1) | GB0604141D0 (xx) |
IL (1) | IL193369A0 (xx) |
NO (1) | NO20083683L (xx) |
NZ (1) | NZ570432A (xx) |
WO (1) | WO2007099329A2 (xx) |
ZA (1) | ZA200806929B (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0501956D0 (en) * | 2005-01-31 | 2005-03-09 | Arrow Internat | Nebulizer formulation |
GB0700380D0 (en) | 2007-01-09 | 2007-02-14 | Breath Ltd | Storage Of Ampoules |
EP3311820A1 (en) * | 2008-02-26 | 2018-04-25 | Sunovion Respiratory Development Inc. | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
US20100055045A1 (en) * | 2008-02-26 | 2010-03-04 | William Gerhart | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
WO2010144628A2 (en) * | 2009-06-09 | 2010-12-16 | Elevation Pharmaceuticals, Inc. | Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration |
US20140296641A1 (en) * | 2013-03-28 | 2014-10-02 | William Randolph Warner | COMPOSITIONS, FORMULATIONS AND METHODS OF BIO-BALANCING THE pH OF STERILE HYPOTONIC, ISOTONIC SALINE AND HYPERTONIC SALINE SOLUTIONS |
GB201416909D0 (en) * | 2014-09-25 | 2014-11-12 | Prosonix Ltd | Method of forming concentrated solution |
CN107233311B (zh) * | 2017-06-27 | 2020-12-04 | 长风药业股份有限公司 | 一种以阿福特罗和格隆溴铵为活性成分的雾化剂及其制备方法 |
US20190231769A1 (en) * | 2017-10-27 | 2019-08-01 | Nephron Pharmaceuticals Corporation | Tiotropium Inhalation Solution for Nebulization |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU673660C (en) * | 1991-12-18 | 2002-07-25 | Astrazeneca Ab | New combination of formoterol and budesonide |
SE9703407D0 (sv) * | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
US6946117B1 (en) * | 1997-09-29 | 2005-09-20 | Nektar Therapeutics | Stabilized preparations for use in nebulizers |
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
SE9802073D0 (sv) * | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
US7074388B2 (en) * | 1998-12-10 | 2006-07-11 | Kos Life Science, Inc. | Water stabilized medicinal aerosol formulation |
US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
IT1313553B1 (it) * | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
US20060171897A1 (en) * | 1999-12-23 | 2006-08-03 | Coifman Robert E | Methods and formulations for the efficient delivery of drugs by nebulizer |
US6451289B2 (en) * | 2000-03-24 | 2002-09-17 | Sepracor Inc. | Albuterol formulations |
GB0009584D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Pharmaceutical compositions |
GB2374013C (en) * | 2000-11-24 | 2009-07-01 | Breath Ltd | Sterilisation of pharmaceuticals |
ITMI20010428A1 (it) * | 2001-03-02 | 2002-09-02 | Chemo Breath S A | Composizioni ad uso inalatorio a base di formoterolo |
US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US20030055026A1 (en) * | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
SE0200312D0 (sv) * | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
DE60325459D1 (de) * | 2002-02-19 | 2009-02-05 | Resolution Chemicals Ltd | Auf lösungsmitteln basierende sterilisation von steroiden |
SE0203376D0 (sv) * | 2002-11-15 | 2002-11-15 | Astrazeneca Ab | New process |
SE526509C2 (sv) * | 2003-06-19 | 2005-09-27 | Microdrug Ag | Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd |
DE10347994A1 (de) * | 2003-10-15 | 2005-06-16 | Pari GmbH Spezialisten für effektive Inhalation | Wässrige Aerosol-Zubereitung |
WO2005044226A2 (en) * | 2003-11-04 | 2005-05-19 | Nectar Therapeutics | Lipid formulations for spontaneous drug encapsulation |
WO2005055978A2 (en) * | 2003-12-12 | 2005-06-23 | Joseph Okpala | A method of engineering particles for use in the delivery of drugs via inhalation |
US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
EP1712220A1 (en) * | 2005-04-15 | 2006-10-18 | PARI GmbH Spezialisten für effektive Inhalation | Pharmaceutical aerosol composition |
-
2006
- 2006-03-01 GB GBGB0604141.2A patent/GB0604141D0/en not_active Ceased
-
2007
- 2007-03-01 CA CA002643761A patent/CA2643761A1/en not_active Abandoned
- 2007-03-01 EP EP07705306A patent/EP1988876A2/en not_active Withdrawn
- 2007-03-01 KR KR1020087021305A patent/KR20080098631A/ko not_active Application Discontinuation
- 2007-03-01 NZ NZ570432A patent/NZ570432A/en not_active IP Right Cessation
- 2007-03-01 JP JP2008556849A patent/JP2009528337A/ja active Pending
- 2007-03-01 BR BRPI0708170-7A patent/BRPI0708170A2/pt not_active IP Right Cessation
- 2007-03-01 WO PCT/GB2007/000722 patent/WO2007099329A2/en active Application Filing
- 2007-03-01 CN CNA2007800071772A patent/CN101394835A/zh active Pending
- 2007-03-01 AU AU2007220288A patent/AU2007220288B2/en not_active Ceased
- 2007-03-01 ZA ZA200806929A patent/ZA200806929B/xx unknown
- 2007-03-01 US US11/680,696 patent/US20070207091A1/en not_active Abandoned
-
2008
- 2008-08-11 IL IL193369A patent/IL193369A0/en unknown
- 2008-08-27 NO NO20083683A patent/NO20083683L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20070207091A1 (en) | 2007-09-06 |
AU2007220288B2 (en) | 2012-12-13 |
GB0604141D0 (en) | 2006-04-12 |
AU2007220288A1 (en) | 2007-09-07 |
WO2007099329A2 (en) | 2007-09-07 |
KR20080098631A (ko) | 2008-11-11 |
NO20083683L (no) | 2008-12-01 |
CN101394835A (zh) | 2009-03-25 |
IL193369A0 (en) | 2009-05-04 |
WO2007099329A3 (en) | 2007-10-25 |
NZ570432A (en) | 2010-09-30 |
JP2009528337A (ja) | 2009-08-06 |
BRPI0708170A2 (pt) | 2011-05-17 |
CA2643761A1 (en) | 2007-09-07 |
EP1988876A2 (en) | 2008-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0608098D0 (en) | Formulation | |
IL195248A0 (en) | Atomiser | |
GB2435419B (en) | Formulations | |
EP2046930A4 (en) | FORMULATIONS BASED ON RHAMNOLIPIDS | |
GB0605780D0 (en) | Formulations | |
PL2007457T3 (pl) | Inhalator | |
IL195247A0 (en) | Inhaler | |
GB0614586D0 (en) | Pharmaceutical Formulation | |
GB0618697D0 (en) | Formulations | |
GB0610336D0 (en) | Formulations | |
ZA200806929B (en) | Nebulizer formulation | |
GB0625312D0 (en) | Formulation | |
GB0625095D0 (en) | Formulation | |
ZA200704977B (en) | Nebulizer formulation | |
GB2434754B (en) | Inhaler | |
GB0612809D0 (en) | Formulation | |
AP2006000208S (en) | Inhaler | |
GB0601304D0 (en) | Herbicide formulation | |
GB0718404D0 (en) | Formulations | |
GB0619592D0 (en) | Biocidal formulation | |
GB0621406D0 (en) | Kirby | |
GB0602261D0 (en) | Atomisation chamber | |
GB0610570D0 (en) | Novel formulation | |
AU311731S (en) | Inhaler | |
GB0605740D0 (en) | Spray |